RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., a highly innovative diagnostic company which is changing the way heart disease, diabetes and other metabolic diseases are assessed and managed, has appointed Daniel J. Levangie to its board of directors.
